BackProteostasis Therapeutics Overview

Proteostasis Therapeutics Net Income

Profitability analysis for PTI.

Quarterly Net Income

-$8.17M
↑ 36.34% YoY

As of Sep 2020

Annual Net Income (TTM)

-$38.80M
↑ 39.54% YoY

Trailing 12 months ending Sep 2020

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin